Optum Ventures-backed Mindstrong Health has raised its series B capital from a consortium that also included new backers Bezos Expeditions and Decheng Capital.

Fosun-backed online pharmacy operator Yaoshibang has added Susquehanna International Group to its shareholders following a series C round raised over two tranches.

StrideBio is based on research conducted at University of North Carolina at Chapel Hill and University of Florida.

The oversubscribed round has been backed by Takeda Ventures, UCB and Alexandria Venture Investments, and was led by Hatteras Venture Partners.

ETH Zurich and University of Zurich spinout InSphero has now raised $35m and will commercialise its organ-on-a-chip technology.

The Arizona spinout plans to develop a biopsy needle that could improve the chances of identifying precision treatments for cancer.